CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-05 | Clifton R. LaDuane CFO, Secretary & Treasurer | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2019-12-31 | Johnson Gordon K Chief Business Officer | Purchase | +10,000 | $0.39 | $4K | 30,000 |
| 2019-12-31 | Johnson Gordon K Chief Business Officer | Purchase | +10,000 | $0.39 | $4K | 40,000 |
| 2019-12-27 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +5,000 | $0.42 | $2K | 17,750 |
| 2019-12-27 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +5,000 | $0.42 | $2K | 22,750 |
| 2019-12-27 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +2,250 | $0.42 | $938 | 25,000 |
| 2019-11-25 | Guenther Sven EVP, Research & Development | Grant or award · Stock Option (right to buy) | +56,000 | 56,000 | ||
| 2019-11-25 | Johnson Gordon K Chief Business Officer | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2019-11-25 | Sangiovanni Timothy J. VP, Corporate Controller | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2019-11-25 | Clifton R. LaDuane CFO, Secretary & Treasurer | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2019-11-25 | Mickle Travis C President & CEO | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2019-09-25 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +3,650 | $0.75 | $3K | 12,750 |
| 2019-09-24 | Sangiovanni Timothy J. VP, Corporate Controller | Purchase | +3,000 | $0.74 | $2K | 6,000 |
| 2019-09-24 | Mickle Travis C President & CEO | Purchase | +10,000 | $0.78 | $8K | 1,713,117 |
| 2019-09-24 | Mickle Travis C President & CEO | Purchase | +5,000 | $0.78 | $4K | 1,718,117 |
| 2019-09-24 | Mickle Travis C President & CEO | Purchase | +15,000 | $0.79 | $12K | 1,733,117 |
| 2019-09-24 | Mickle Travis C President & CEO | Purchase | +5,000 | $0.80 | $4K | 1,738,117 |
| 2019-09-24 | Mickle Travis C President & CEO | Purchase | +5,000 | $0.79 | $4K | 1,743,117 |
| 2019-09-24 | Mickle Travis C President & CEO | Purchase | +5,000 | $0.78 | $4K | 1,748,117 |
| 2019-09-24 | Mickle Travis C President & CEO | Purchase | +5,000 | $0.79 | $4K | 1,753,117 |
Page 14 of 16 · 319 trades